Immunic, Inc. (IMUX)
NASDAQ: IMUX · Real-Time Price · USD
1.000
-0.040 (-3.85%)
At close: Dec 20, 2024, 4:00 PM
1.020
+0.020 (2.00%)
After-hours: Dec 20, 2024, 6:37 PM EST
Immunic Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Selling, General & Admin | 18.09 | 16.01 | 15.26 | 13.3 | 10.33 | 14.52 | |
| Research & Development | 77.71 | 83.22 | 71.26 | 61.12 | 38.64 | 22.51 | |
| Operating Expenses | 95.8 | 99.22 | 86.52 | 74.42 | 48.97 | 37.03 | |
| Operating Income | -95.8 | -99.22 | -86.52 | -74.42 | -48.97 | -37.03 | |
| Interest & Investment Income | 3.5 | 3.08 | 1.04 | 0.07 | 0.06 | 0.11 | |
| Currency Exchange Gain (Loss) | - | - | - | - | 2.5 | - | |
| Other Non Operating Income (Expenses) | 0.19 | 2.54 | -1.96 | -1.35 | 2.4 | 1.69 | |
| EBT Excluding Unusual Items | -92.11 | -93.61 | -87.44 | -75.7 | -44.02 | -35.24 | |
| Impairment of Goodwill | - | - | -32.97 | - | - | - | |
| Gain (Loss) on Sale of Investments | - | - | - | - | - | -0.1 | |
| Other Unusual Items | - | - | - | -17.25 | - | 0.41 | |
| Pretax Income | -96.9 | -93.61 | -120.41 | -92.95 | -44.02 | -34.93 | |
| Net Income | -96.9 | -93.61 | -120.41 | -92.95 | -44.02 | -34.93 | |
| Net Income to Common | -96.9 | -93.61 | -120.41 | -92.95 | -44.02 | -34.93 | |
| Shares Outstanding (Basic) | 86 | 44 | 32 | 24 | 16 | 8 | |
| Shares Outstanding (Diluted) | 86 | 44 | 32 | 24 | 16 | 8 | |
| Shares Change (YoY) | 101.53% | 39.29% | 34.53% | 51.00% | 102.84% | 811.77% | |
| EPS (Basic) | -1.12 | -2.11 | -3.78 | -3.93 | -2.81 | -4.52 | |
| EPS (Diluted) | -1.12 | -2.11 | -3.78 | -3.93 | -2.81 | -4.52 | |
| Free Cash Flow | -76.26 | -71.16 | -65.26 | -83.3 | -46.27 | -28.6 | |
| Free Cash Flow Per Share | -0.89 | -1.61 | -2.05 | -3.52 | -2.95 | -3.70 | |
| EBITDA | -95.68 | -99.11 | -86.44 | -74.33 | -48.93 | -36.98 | |
| D&A For EBITDA | 0.12 | 0.11 | 0.08 | 0.09 | 0.04 | 0.05 | |
| EBIT | -95.8 | -99.22 | -86.52 | -74.42 | -48.97 | -37.03 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.